Digital therapeutics for Substance Use Disorders: Research priorities and clinical validation
Drug Alcohol Depend
.
2021 Dec 1;229(Pt A):109120.
doi: 10.1016/j.drugalcdep.2021.109120.
Epub 2021 Oct 9.
Authors
Will M Aklin
1
,
Kevin M Walton
2
,
Patrick Antkowiak
3
Affiliations
1
National Institute on Drug Abuse, Division of Therapeutics and Medical Consequences, United States. Electronic address: aklinwm@mail.nih.gov.
2
National Institute on Drug Abuse, Division of Therapeutics and Medical Consequences, United States.
3
Food and Drug Administration, Center for Devices and Radiological Health, Office of Neurological and Physical Medicine Devices, United States.
PMID:
34740068
DOI:
10.1016/j.drugalcdep.2021.109120
No abstract available
Keywords:
Behavioral interventions; Digital therapeutics; FDA authorization process.
MeSH terms
Humans
Research
Substance-Related Disorders* / therapy